Log in to save to my catalogue

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circula...

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circula...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_73d080e2f61b4541b21002f7252ee34c

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA

About this item

Full title

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2022-11, Vol.20 (1), p.458-458, Article 458

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Pancreatic ductal adenocarcinoma (PDAC) has the lowest overall survival rate primarily due to the late onset of symptoms and rapid progression. Reliable and accurate tests for early detection are lacking. We aimed to develop a noninvasive test for early PDAC detection by capturing the circulating tumour DNA (ctDNA) methylation signature in blood.

Alternative Titles

Full title

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_73d080e2f61b4541b21002f7252ee34c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_73d080e2f61b4541b21002f7252ee34c

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-022-02647-z

How to access this item